par Massaro, Fulvio;Corrillon, Florent ;Stamatopoulos, Basile ;Meuleman, Nathalie ;Lagneaux, Laurence ;Bron, Dominique
Référence Cancers (Basel), 13, 1, page (1-22), 68
Publication Publié, 2021-01
Référence Cancers (Basel), 13, 1, page (1-22), 68
Publication Publié, 2021-01
Article révisé par les pairs
Résumé : | Aging of bone marrow is a complex process that is involved in the development of many diseases, including hematologic cancers. The results obtained in this field of research, year after year, underline the important role of cross-talk between hematopoietic stem cells and their close environment. In bone marrow, mesenchymal stromal cells (MSCs) are a major player in cell-to-cell communication, presenting a wide range of functionalities, sometimes opposite, depending on the environmental conditions. Although these cells are actively studied for their therapeutic properties, their role in tumor progression remains unclear. One of the reasons for this is that the aging of MSCs has a direct impact on their behavior and on hematopoiesis. In addition, tumor progression is accompanied by dynamic remodeling of the bone marrow niche that may interfere with MSC functions. The present review presents the main features of MSC senescence in bone marrow and their implications in hematologic cancer progression. |